Trial intelligence / Profile preview

Pharmacological Treatment of Hypoglycemia After Gastric Bypass

NCT02527993Phase 4Completed

Sponsor
Zealand University Hospital
Start
Oct 2015
Primary completion
Apr 2017
Modality
Peptides, Small Molecules
01

Overview

A Phase 4 trial of acarbose, sitagliptin, verapamil, liraglutide, pasireotide LAR in Postprandial hyperinsulinemic hypoglycemia (PHH), sponsored by Zealand University Hospital. Started Oct 2015; status: completed.

02

Drugs

acarbosesitagliptinverapamilliraglutidepasireotide LAR
03

Conditions

Postprandial hyperinsulinemic hypoglycemia (PHH)

Beyond the preview

Go deeper on NCT02527993.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02527993.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call